KATHLEEN BOONE: Open Payments
NPI 1538143391 · PAWLEYS ISLAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 71 payments from 21 companies in 2025. Trend: 2023 $2,190 · 2024 $1,794 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $242 |
| Amgen Inc. | 8 | $179 |
| ABBVIE INC. | 7 | $175 |
| AstraZeneca Pharmaceuticals LP | 9 | $151 |
| GlaxoSmithKline, LLC. | 7 | $128 |
| Exact Sciences Corporation | 4 | $68 |
| SANOFI-AVENTIS U.S. LLC | 2 | $64 |
| Xeris Pharmaceuticals, Inc. | 2 | $56 |
| Alkermes, Inc. | 2 | $56 |
| Abbott Laboratories | 2 | $46 |
Products named: OTEZLA, QULIPTA, Wegovy, TRELEGY ELLIPTA, Ozempic, FARXIGA, Cologuard Collection Kit, TZIELD.
Industry payments across SC — which companies pay providers there.
